GlassScriptPhysician profile
Deana Roper
NPI 1093243305
$3,876.97
in general payments reported to CMS, 2019-2025
29 companies · $780 in 2025
The $780 reported for 2025 was more than what 84% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $554 · 2022: $882 · 2023: $991 · 2024: $669 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,440.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $879.85 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Alnylam Pharmaceuticals INC. | $347.91 | 2022-2025 | Amvuttra, Onpattro |
| Astrazeneca Pharmaceuticals LP | $336.14 | 2022-2024 | Airsupra |
| Novartis Pharmaceuticals Corporation | $334.61 | 2022-2025 | |
| Boston Scientific Corporation | $193.55 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $163.06 | 2022-2025 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $160.96 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $153.85 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $145.90 | 2023 | Camzyos |
| Biohaven Pharmaceuticals, INC. | $138.78 | 2021 | |
| Scpharmaceuticals INC. | $136.09 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.40 | 2023 | Jardiance |
| Medtronic, INC. | $85.20 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $73.62 | 2024-2025 | Opsumit, Uptravi |
| Kestra Medical Technology Services, INC. | $68.75 | 2024-2025 | Assure Wcd |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.94 | 2021-2022 | |
| Pfizer INC. | $63.58 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $60.95 | 2022-2023 | Verquvo |
| Heartflow, INC. | $57.13 | 2022-2025 | |
| Biodelivery Sciences International, INC. | $54.84 | 2021 | |
| Cvrx, INC. | $54.53 | 2022-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $34.34 | 2022-2023 | Xarelto |
| Abiomed | $33.65 | 2025 | |
| Solventum Corporation | $26.80 | 2024 | V.A.C.Instill, Prevena |
| Impulse Dynamics (USA) INC. | $23.81 | 2022 | |
| Redhill Biopharma INC. | $18.15 | 2021 | |
| Grt US Holding, INC. | $16.20 | 2021 | |
| Vifor Pharma, INC. | $15.36 | 2022 | |
| Amgen INC. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deana Roper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.